-
All localities will accelerate the formulation of standards for traditional Chinese medicine formula granules, and pharmaceutical companies will usher in more challenges
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];Chinese medicine formula granules are granules made of single flavor Chinese medicine pieces by water extraction, separation, concentration, drying and granulation, under the guidance of Chinese medicine theory, according to the clinical prescription of Chinese medicine, can be used by patients, belonging to the management category of Chinese medicine pieces.
-
Guangdong Provincial Food and Drug Administration: Sufficient supply of drugs, no need to blindly "stock up on drugs
Time of Update: 2023-01-01
According to the "Guangdong Drug Administration" public account news on December 3, recently, the "new crown medicine order" chart, "new crown drug hoarding list" and so on have gone viral on social platforms, and many citizens and friends have also begun to follow the trend of hoarding medicine, is it really necessary?
-
FDA lifts restrictions on clinical studies of Magrolimab in MDS and AML
Time of Update: 2022-05-21
S. Food and Drug Administration (FDA) has lifted the hold on clinical studies of the investigational drug magrolimab in combination with azacitidine in the treatment of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) .
-
NEJM: Short-term treatment of non-severe tuberculosis in children in Africa and India
Time of Update: 2022-04-19
immune infectionThus, for children with drug-sensitive, non-severe, smear-negative tuberculosis, 4-month anti-TB treatment was not inferior to 6-month treatment .
For children with drug-sensitive, non-severe, smear-negative TB, 4 months of anti-TB treatment was noninferior to 6 months of treatment .
-
How is pharmacovigilance done
Time of Update: 2022-02-23
The World Health Organization has a specific definition of this term, which is called the discovery, assessment, understanding and prevention of adverse drug reactions or any other drug-related problems, sciences and activities .
-
Shanghai Pharmaceuticals duloxetine hydrochloride enteric-coated tablets passed the consistency evaluation of generic drugs
Time of Update: 2021-06-17
(hereinafter referred to as “Shanghai Pharmaceuticals Zhongxi”) has received the relevant duloxetine hydrochloride enteric-coated tablets issued by the State Food and Drug Administration.
In January 2020, Shanghai Pharmaceuticals Zhongxi submitted an application to the State Food and Drug Administration for the consistency evaluation of the generic drug and was accepted .
-
The first IgA nephropathy (IgAN) treatment
Time of Update: 2021-05-08
com/fda/" target="_blank">FDAIf approved, Nefecon will become the first therapy specifically designed and approved for the treatment of IgAN, with disease correction potential.
-
Ascent Pharmaceuticals Nectinib is included in the proposed breakthrough treatment, and it is China's first BCR-ABL targeted CML drug
Time of Update: 2021-04-27
Screenshot source: CDE official website HQP1351 is an original Class 1 new drug under research by Ascent Pharmaceuticals, a new third-generation BCR-ABL tyrosine kinase inhibitor (Tyrosine Kinase Inhibitor, TKI), used to treat first- and second-generation TKI resistance Chronic Myelogenous Leukemia (CML), especially for CML patients with T315I mutation, has a good effect.
-
Yuandong biological hair! Heng Rui just took the first imitation injection to welcome the second
Time of Update: 2020-10-31
Recently, NMPA official website data show that Chengdu Yuandong Biopharmaceutical's Grombrom ammonium injection class 3 imitation listing application has entered the "in the approval" state. October
-
APL-106 Treatment of Acute Myeloid Leukemia: Phase III Briddle Study will be initiated
Time of Update: 2020-10-12
Biopharmaceutical company Apollomic announced today that APL-106 (uproleselan) has been approved by china's National Drug Administration (NMPA) Drug Review Center (CDE) to conduct a Phase III briditation study of APL-106 (uproleselan) in combination with chemotherapy to treat recurrence/difficult acute myeloid leukemia (AML).
-
State Drug Administration: The penalty decision of counterfeit and inferior drugs does not require the conclusion of drug quality inspection
Time of Update: 2020-07-21
On July 14th, the State Drug Administration issued a "Reply Letter from the General Department of the State Drug Administration on the issue of the identification of counterfeit and inferior drugs",
-
Heavy! Hengrui's innovative drug toluene sulphate rematomamyloscopy sedatives were approved
Time of Update: 2020-07-18
Guide: Injection of toluene sulfonate is a benzodiazepine class of drugs, is a new type of short-acting GABAa receptor agonists recently, Hengrui Pharmaceuticals received the approval of the State D
-
[quick news] February 7, 2020 Russian media: Russia provides China with a new crown diagnosis system, which can provide doctors with treatment suggestions
Time of Update: 2020-02-07
Russian media: China novel coronavirus diagnostic system can provide doctors with treatment recommendations Russian media said Victor Fersht, executive secretary of WHO project center, said Chinese me
-
Immunotherapy for lung cancer! Mosadon keytruda combined with first-line chemotherapy significantly prolonged progression free survival, not related to KRAS mutation
Time of Update: 2019-12-17
December 17, 2019 / BIOON / -- cancer immunotherapy giant Merck & Co recently released exploratory analysis data of key phase III keynote-189 (nct02578680) study of lung cancer The results showed that
-
Valante confirms acquisition of female Viagra manufacturer sprout
Time of Update: 2015-08-21
Source: Valeant pharmaceuticals International (NYSE: VRx) confirmed that the company will acquire sprout pharmaceuticals with about $1 billion in cash, and the transaction is expected to be completed
